Sequential transarterial chemoembolisation and stereotactic body radiotherapy followed by immunotherapy as conversion therapy for patients with locally advanced, unresectable hepatocellular carcinoma (START-FIT): a single-arm, phase 2 trial-Reference-Cited by-同舟云学术

Sequential transarterial chemoembolisation and stereotactic body radiotherapy followed by immunotherapy as conversion therapy for patients with locally advanced, unresectable hepatocellular carcinoma (START-FIT): a single-arm, phase 2 trial

Published:2023-02 Issue:2 Volume:8 Page:169-178
ISSN:2468-1253
Container-title:The Lancet Gastroenterology & Hepatology
language:en
Short-container-title:The Lancet Gastroenterology & Hepatology

Author:

Chiang Chi Leung,Chiu Keith Wan Hang,Chan Kenneth Sik Kwan,Lee Francis Ann Shing,Li James Chun Bong,Wan Catherine Wing Suet,Dai Wing Chiu,Lam Tai Chung,Chen Wenqi,Wong Natalie Sean Man,Cheung Andy Lai Yin,Lee Venus Wan Yan,Lau Vince Wing Hang,El Helali Aya,Man Kwan,Kong Feng Ming (Spring),Lo Chung Mau,Chan Albert Chi-Yan

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference30 articles.

1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J Clin,2021

2. Local radiotherapy as a complement to incomplete transcatheter arterial chemoembolization in locally advanced hepatocellular carcinoma;Shim;Liver Int,2005

3. A changing paradigm for the treatment of intermediate-stage hepatocellular carcinoma: Asia-Pacific primary liver cancer expert consensus statements;Kudo;Liver Cancer,2020

4. Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial;Kudo;Lancet,2018

5. Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma;Finn;N Engl J Med,2020

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Opportunities and challenges of multidisciplinary conversion therapy in advanced hepatocellular carcinoma;Current Cancer Reports;2024-09-11

2. Abscopal effect: from a rare phenomenon to a new frontier in cancer therapy;Biomarker Research;2024-09-04

3. Liver transplantation for hepatocellular carcinoma: Current status in Hong Kong, China;Hepatobiliary & Pancreatic Diseases International;2024-09

4. The efficacy and safety of Radiofrequency ablation combined with Lenvatinib plus Sintilimab in Unresectable Hepatocellular Carcinoma: a real-world study;BMC Cancer;2024-08-22

5. Systemic conversion therapies for initially unresectable hepatocellular carcinoma: a systematic review and meta-analysis;BMC Cancer;2024-08-14